Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1
Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.
Related Posts
Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]
Nouh A, Olson D, Liang H, Koriesh A, Ali M, Bashir MMI, Mukerjee P, Man S, Fonarow GC. In-Hospital Stroke Quality and Outcomes in the[...]
Ahmed M, Hashmi TM, Shahzad M, Zia R, Ashraf H, Ahmed R, Rashid M, Greene SJ, Mentz RJ, Fudim M, Fonarow GC, Rana JS. Cardiovascular[...]